PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBAug 16, 2024 | Webinars. With the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates thorough preparation and strategic planning during the design phase. Addressing these challenges early is crucial ...
Moderna shares positive phase 3 results for mRNA influenza …
WEBSep 15, 2023 · Moderna has shared positive results from a late-stage trial of its influenza vaccine, with mRNA-1010 shown to generate a stronger immune response against all four World Health Organization (WHO)-recommended flu strains compared to GSK’s Fluarix. Improved immunogenicity was observed across age …
PME - PMLiVE
WEBPharmaceutical Market Europe – October 2023. Launch excellence – adapting to data disruption; preparing for the clinical trials of the future; the impact of cell therapies on cancer treatments.
Healthcare - PMLiVE
WEBEli Lilly commits further $6.5m to UNICEF for young people at risk of noncommunicable diseases. The new funding builds on the company’s initial commitment of $14.4m in 2022. JCVI announces advice for autumn COVID-19 vaccination programme eligibility. The Committee has advised offering the vaccine to those at high risk of serious disease.
PME - Home
WEBHow AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate.
Gates Medical Research Institute initiates phase 3 study of ...
WEBMar 21, 2024 · The Bill & Melinda Gates Medical Research Institute (Gates MRI) has announced the initiation of a phase 3 clinical trial to evaluate the efficacy of a new vaccine candidate to protect adolescents and adults from pulmonary tuberculosis (TB).. If effective, the M72/AS01E vaccine could be the first available to help prevent pulmonary TB and the first new TB vaccine in over a century.
The handover: Pfizer reshapes itself for a new era - PMLiVE
WEBNov 8, 2018 · Pfizer has just reported Q3 sales up 1% to $13.3bn, slightly below analysts’ forecasts, but still on course for a solid performance in 2018. Innovative health revenue increased 4% to $8.47bn, lifted by sales of blood thinner Eliquis and breast cancer drug Ibrance outside the US, among others. Pfizer’s chief financial officer and executive ...
Pfizer to expand Paxlovid manufacturing in US to meet global …
WEBJun 7, 2022 · Pfizer has announced plans to invest $120m to produce its oral treatment for COVID-19, Paxlovid, in the US, with the expansion creating more than 250 high-skilled manufacturing jobs at the company’s site in Michigan.
Sanofi/Regeneron’s Dupixent shows promise in chronic obstructive ...
WEBMay 24, 2023 · Sanofi and Regeneron’s Dupixent (dupilumab) was associated with significant improvements in uncontrolled chronic obstructive pulmonary disease (COPD), according to positive phase 3 results presented at the 2023 American Thoracic Society International Conference. The results from the BOREAS trial, which met the primary and all …
AstraZeneca presents positive phase 3 results for Imfinzi ... - PMLiVE
WEBApr 18, 2023 · AstraZeneca’s (AZ) Imfinzi has shown promising results when used before and after surgery in resectable early-stage non-small cell lung cancer (NSCLC), according to new phase 3 data presented at the American Association for Cancer Research Annual Meeting. Interim results from the AEGEAN study, which is …